Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours

Clinical trial NCT02992912 · UNKNOWN

Trial details

NCT number: NCT02992912
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Patients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma )

Start date: 2016-11-15
Primary completion: 2022-05-20
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.